Admetsys, a company headquartered in Boston, has developed a system for controlling blood glucose levels in critical care patients. Essentially an artificial pancreas, the system relies on a lab-on-a-chip that’s embedded within an intravenous catheter to measure glucose and lactic acid, automatically supplying insulin or glucose to keep the patient within normal range.
Measurements are done about every five minutes, and since sensing is embedded there’s no blood drawn out of the patient, no fingers are pricked. Moreover, once the catheter is placed and the system is initiated, there’s nothing for a nurse to do in terms of blood sugar regulation.
The system is moving through the regulatory frameworks in the U.S. and Europe, but the company has yet to receive any approvals.
Here’s Timothy Valk, the co-founder and Chief Scientist of Admetsys, discussing the company and its technology on CNBC:
Admetsys on its artificial pancreas for treating diabetes from CNBC…
You may be interested
Calif. fines Anthem $5M for failing to resolve consumer grievances in timely mannerFrank - Nov 21, 2018
California’s managed-care regulator announced Wednesday it has fined insurance giant Anthem Blue Cross $5 million for repeatedly failing to resolve…
Zeal & Ardor, Club Bahnhof Ehrenfeld, gig review: Black chain gang metal proves intoxicating in a live settingFrank - Nov 21, 2018
Frank's source: http://www.independent.co.uk/arts-entertainment/music/reviews/zeal-ardor-club-bahnhof-ehrenfeld-gig-review-a7968011.html
Father of teenage ‘Cash Me Outside’ girl warns she is being exploitedFrank - Nov 21, 2018
Frank's source: http://www.independent.co.uk/arts-entertainment/music/news/cash-me-outside-girl-father-singer-sexualised-exploited-atlantic-records-ira-peskowitz-a7968211.html